How can pharma teams optimise their HCP portals to strengthen HCP relationships and impact patient outcomes?
- Customer Experience
In January of 2023, there was a lot of noise in the media about the advancement of AI. We were thinking about its transformative potential for healthcare and decided to get the views of the chatbot at the centre of all this. Graphite CEO, Rob Verheul, puts his questions to ChatGPT.
We loaded up ChatGPT and engaged in a conversation about the technology and possibilities for the future of communication with HCPs and patients.
From text assistance to data analysis and drug discovery, there appear to be many applications for AI as a partner in the healthcare and pharmaceutical industry. ChatGPT has answered and the responses speak for themselves in terms of the transformative effect this could have on not only healthcare but the way the industry is organised.
ChatGPT: ChatGPT is a language model developed by OpenAI, designed to generate human-like text based on the input it receives. It has been trained on a massive amount of diverse text data from the internet and has the ability to respond to a wide range of topics and questions.
You should care about ChatGPT because it can be useful for a variety of applications, such as conversational AI systems for customer service, language translation, and text generation for creative writing or content creation. It also showcases the advancements in AI technology and its potential to shape the future.
ChatGPT: Language models like ChatGPT have the potential to be disruptive in the life sciences industry for several reasons:
ChatGPT: The use of language models like ChatGPT in healthcare has the potential to impact the doctor-patient relationship in several ways.
As we can see above, the technology produces valuable content, which is not only contextually aware but demonstrates an astounding grasp of natural language.
Even though the underlying technologies have been available for a number of years ChatGPT has taken the spotlight, having made them accessible to all. ChatGPT capabilities indicate a leap forward in human-computer relationships and has the potential to disrupt the field of medicine and life sciences immensely. From the development of drugs to communications with HCPs and patient support, in evolutionary terms, the ‘chatbot’ has seemingly gone from ape to toddler within a matter of months. But as ChatGPT itself highlights, we do need to pause and consider the ethical implications. The trust that the user has for AI output, and who ultimately has liability, will be of particular importance when it comes to those using its information.
Whilst there is plenty of noise about ChatGPT, it might be some time yet before society trusts AI to direct its healthcare pathways, but no doubt we’ll see these technologies introduced sooner rather than later - disrupting the norms in drug development, patient and HCP relationships.
We are digital innovation specialists in the healthcare and pharma industry. We are actively looking for client partners exploring new ways of engaging with HCPs and patients. If you are exploring AI and what it can do practically in your digital customer experience, we’d love to hear from you.